West African coast emerges as key source of microlitter in the South Atlantic Ocean
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-Jun-2026 04:16 ET (8-Jun-2026 08:16 GMT/UTC)
Most of the microlitter present in the South Atlantic Ocean originates from the West African coast and is particularly concentrated in areas near the equator and off the coast of Brazil. This is demonstrated by a study conducted by the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB), Spain, which has successfully identified in detail the main geographical sources of these microparticles, their large-scale distribution, and the processes that drive their accumulation in the ocean.
In agricultural production, fertilizer application is a key measure to ensure high crop yields. However, excessive or unreasonable fertilization methods often lead to the loss of large amounts of nitrogen and phosphorus nutrients into water bodies through runoff and leaching, triggering environmental problems such as lake eutrophication.
An international team led by Dr. Adolfo Poma (IPPT PAN, Poland) shows that antibody effectiveness depends not only on binding strength but also on their stability under mechanical forces. The findings provide a new framework for designing more robust antiviral therapeutics.
The first atlas of the female reproductive system shows menopause as a turning point that reorganizes organs and tissues, revealing that they do not all age at the same rate.
The study used artificial intelligence and the supercomputing power of MareNostrum 5 to analyze more than 1,000 tissue images and the expression of thousands of genes in 659 samples from 304 women.
The results open the door to detecting blood biomarkers that would allow non-invasive monitoring of reproductive aging and its associated risks.
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness. The study, published in the April 29, 2026 online issue of Nature Biotechnology https://doi.org/10.1038/s41587-026-03099-z], also introduces a powerful and versatile technology to control the expression of mRNA drugs, which the researchers demonstrate can enhance the effectiveness of mRNA cancer vaccines in preclinical studies of lymphoma. The findings provide a new framework for designing mRNA vaccines and mRNA therapeutics, with immediate implications for cancer immunotherapy, infectious disease vaccines, and gene-editing treatments.
The platform integrates multi-omic data to drive both biomedical research and clinical practice.
Its technology, based on Graph Foundation Models, extracts robust conclusions even from the limited and heterogeneous samples typical of the biomedical field.